Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2024

Jul 17, 2024

30403_dirs_2024-07-17_747bdb5f-c743-40e5-a113-5f312be065cf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2024-07-15

Reporting Person: Hyder Chris T (Group President - Health & Hyg)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-07-15 Common Stock A 2981.0000 $134.1500 Acquired 13770.0000 Direct

Footnotes

F1: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.